Additionally, development of a multifunctional nanoparticle designed to target cancer stem cells was found to exert at least some of its effect through the inhibition of Hsp90 secretion, suggesting another avenue for potential therapeutics (Liu et al., 2019). Here, HSP90AA1 is linked to cancer.